1. Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies

   • Øystein Bruserud
   • Tor Henrik Anderson Tvedt
   • Håkon Reikvam

   Review 05 July 2014 Pages: 757 - 777

2. Immunologic hierarchy, class II MHC promiscuity, and epitope spreading of a melanoma helper peptide vaccine

   • Yinin Hu
   • Gina R. Petroni
   • Craig L. Slingluff Jr.

   Original Article 23 April 2014 Pages: 779 - 786

   

3. Antitumor activity and safety of combination therapy with the Toll-like receptor 9 agonist IMO-2055, erlotinib, and bevacizumab in advanced or metastatic non-small cell lung cancer patients who have progressed following chemotherapy

   • David A. Smith
   • Paul Conkling
   • Alice S. Bexon

   Original Article 27 April 2014 Pages: 787 - 796

   

4. Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis

   • Masanori Kobayashi
   • Shigetaka Shimodaira
   • The DC Vaccine Study Group at the Japan Society of Innovative Cell Therapy (J-SICT)

   Original Article 29 April 2014 Pages: 797 - 806

   

5. Altered chemokine production and accumulation of regulatory T cells in intestinal adenomas of APC^Min/+ mice

   • Paulina Akeus
   • Veronica Langenes
   • Marianne Quiding-Järbrink

   Original Article 29 April 2014 Pages: 807 - 819

   

6. Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy

   • Claudia Brehm
   • Sabine Huenecke
   • Ulrike Koehl

   Original Article 08 May 2014 Pages: 821 - 833

   

7. Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy

   • Jungsun Park
   • Haiyan Li
   • Qing Yi

   Original Article 20 May 2014 Pages: 835 - 845

   

8. Combination of an agonistic anti-CD40 monoclonal antibody and the COX-2 inhibitor celecoxib induces anti-glioma effects by promotion of type-1 immunity in myeloid cells and T-cells

   • Akemi Kosaka
   • Takayuki Ohkuri
   • Hideho Okada

   Original Article 31 May 2014 Pages: 847 - 857

   

9. B7-H1 signaling is integrated during CD8⁺ T cell priming and restrains effector differentiation

   • Rachel M. Gibbons
   • Xin Liu
   • Haidong Dong

   Original Article 04 June 2014 Pages: 859 - 867